Abstract
Background: Ciprofloxacin is a common and widely used antibiotic in both human and animal health, But indiscriminate, overdose and long term used may cause toxicity The research work was designed to examine the changes in hematological parameters: Total Erythrocyte count (TEC), Hemoglobin (Hb), Total Leukocyte Count (TLC) and Differential Leukocyte Count (DLC) and biochemical parameters: Total Cholesterol (T), Triglyceride (TG), High Density Lipoprotein (HDL) and Serum Creatinine (SC) in mice treated with ciprofloxacin and its interaction with vitamin C. Methods: A total of 20 male Swiss Albino mice aging one month and weighing of 22.5±2.3 gm were taken, and were allotted into four equal groups (n=5). After acclimatization, Group D was kept as control and was fed with normal mice pellet and water only. Mice of group A, B, and C were maintained as treatment groups and fed with ciprofloxacin (Ciprocin® )@ 2 mg/kg body weight (bwt), 1 mg/kg bwt and 0.5 mg/kg bwt in normal saline orally respectively throughout the experimental period of 14 days. Besides 2 mg Vitamin C @ 2mg /kg bwt was supplied in water for all the treated mice. Results: The results indicated that the values of RBC and Hb in the treated groups were decreased significantly (P<0.01) as compared to the control group. White blood cell (WBC) counts in group B and C were almost similar to those of control group, whereas it was lowered significantly (P<0.05) in group A. However, lymphocyte, monocyte levels significantly (P<0.01) increased in all the treated groups as compared to the control, whereas neutrophil and eosinophil counts in group B and C were lowered (P<0.01) as compared to the control. The TG values were recorded as lower (P<0.01) in group C than in group A. Cholesterol level was found highest (P<0.01) in control mice (group D) as compared to treated groups A, B and C. HDL was decreased and SC was increased significantly (P<0.01) in the treated groups as compared to the control group. Conclusions: It could be concluded that treatment mice with vitamin C concomitantly with ciprofloxacin not exert restoring effect significantly on hematological parameters of TEC and Hb but exert effect significantly on total WBC count, lymphocyte, monocyte and lipid profile.
Highlights
Ciprofloxacin has a good bioavailability after oral administration, good to excellent tissue penetration and is relatively safe (Ball and Tillotson, 1995; Papich, 1998)
It could be concluded that treatment mice with vitamin C concomitantly with ciprofloxacin not exert restoring effect significantly on hematological parameters of Total Erythrocyte count (TEC) and Hb but exert effect significantly on total White blood cell (WBC) count, lymphocyte, monocyte and lipid profile
Effect on hematological parameters Administration of mice with three different doses of ciprofloxacin during the experimental period (14 days) produced a dose dependent significant decrease (P
Summary
A total of 20 male Swiss Albino mice aging one month and weighing of 22.5±2.3 gm were taken, and were allotted into four equal groups (n=5). Group D was kept as control and was fed with normal mice pellet and water only. Mice of group A, B, and C were maintained as treatment groups and fed with ciprofloxacin (Ciprocin® )@ 2 mg/kg body weight (bwt), 1 mg/kg bwt and 0.5 mg/kg bwt in normal saline orally respectively throughout the experimental period of 14 days. Besides 2 mg Vitamin C @ 2mg /kg bwt was supplied in water for all the treated mice
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
